A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Anti-TNFa Biologics
Clinical trial NCT01636817 · TERMINATED
Trial details
- NCT number
- NCT01636817
- Sponsor
- Novo Nordisk A/S
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-01
- Primary completion
- 2014-11-01
- Enrollment
- 239
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.